Dose modification rules and availability of growth factor support: a cross-sectional study of head-to-head cancer trials used for us fda approval from 2009 to

HIGHLIGHTS

• who: Timothu00e9e Olivier from the Department of, Geneva University Hospital, Gabrielle-Perret-Gentil Street, Geneva, Switzerland have published the paper: Dose modification rules and availability of growth factor support: A cross-sectional study of head-to-head cancer trials used for US FDA approval from 2009 to, in the Journal: (JOURNAL)
• what: The authors aimed to estimate the prevalence of unequal rules for dose modification rules or the use of myeloid growth factors in head-to-head registration Food and Administration trials.
• how: The authors compared proportions with the ManneWhitney U Test (Wilcoxon . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.